Page 805«..1020..804805806807..810820..»

Clene Nanomedicine Announces Over 50% of Subjects Randomized in RESCUE-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with…

Posted: Published on May 30th, 2020

SALT LAKE CITY, May 26, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announcedits Australian subsidiary has completed over 50% of participant randomization in the Phase 2 RESCUE-ALS study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Amyotrophic Lateral Sclerosis (ALS). Continue reading →

Posted in ALS Treatment | Comments Off on Clene Nanomedicine Announces Over 50% of Subjects Randomized in RESCUE-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with…

AMG Mourns the Loss of Sean M. Healey, Founder, Executive Co-Chairman, and Former CEO – GlobeNewswire

Posted: Published on May 30th, 2020

May 27, 2020 17:14 ET | Source: Affiliated Managers Group, Inc. WEST PALM BEACH, Fla., May 27, 2020 (GLOBE NEWSWIRE) -- Affiliated Managers Group, Inc. (NYSE: AMG), a global asset management company, today announced with sadness the passing of Sean M Continue reading →

Posted in ALS Treatment | Comments Off on AMG Mourns the Loss of Sean M. Healey, Founder, Executive Co-Chairman, and Former CEO – GlobeNewswire

Eurordis Urges Expansion of Newborn Screening Initiatives Across… – ALS News Today

Posted: Published on May 30th, 2020

European authorities must step up efforts to screen babies for a multitude of genetic disorders, a panel of experts suggested during a May 14-15 online medical conference. The session was part of the 10th European Conference on Rare Diseases & Orphan Products (ECRD2020) which was to have occurred in Stockholm, but instead took place online via Zoom. Were interested in this topic because our community feels poorly served by newborn screening, said Nick Meade, policy director at Genetic Alliance UK, a national charity representing more than 230 British patient advocacy organizations. Continue reading →

Posted in ALS Treatment | Comments Off on Eurordis Urges Expansion of Newborn Screening Initiatives Across… – ALS News Today

Orphazyme initiates rolling submission of New Drug Application for arimoclomol with US FDA in Niemann-Pick disease Type C – Yahoo Finance

Posted: Published on May 30th, 2020

Orphazyme A/S Company announcement No. 34/2020 Company Registration No. Continue reading →

Posted in ALS Treatment | Comments Off on Orphazyme initiates rolling submission of New Drug Application for arimoclomol with US FDA in Niemann-Pick disease Type C – Yahoo Finance

Hormone Replacement Therapy Market with (Covid-19) Impact Analysis: Forecast to Show Spurring Growth by 2020-2027 – Cole of Duty

Posted: Published on May 29th, 2020

A leading research firmZion Market researchadded a recent report on Hormone Replacement Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024 to its research database. The Hormone Replacement Therapy comprehensive is perceptible among the most immensely gathered market globally. The Hormone Replacement Therapy report gives the exchange information and the progressing business chain information in the overall market Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy Market with (Covid-19) Impact Analysis: Forecast to Show Spurring Growth by 2020-2027 – Cole of Duty

Hormone Replacement Therapy Market : Facts, Figures and Analytical Insights 2020 2029 – Germany English News

Posted: Published on May 29th, 2020

The research study on Global Hormone Replacement Therapy market 2019 presents an extensive analysis of current Hormone Replacement Therapy market size, drivers, trends, opportunities, challenges, as well as key Hormone Replacement Therapy market segments. Further, it explains various definitions and classification of the Hormone Replacement Therapy industry, applications, and chain structure.In continuation of this data, the Hormone Replacement Therapy report covers various marketing strategies followed by key players and distributors. Also explains Hormone Replacement Therapy marketing channels, potential buyers and development history Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy Market : Facts, Figures and Analytical Insights 2020 2029 – Germany English News

Merck’s KEYTRUDA (pembrolizumab) Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer – Maryville Daily Times

Posted: Published on May 29th, 2020

KENILWORTH, N.J.--(BUSINESS WIRE)--May 28, 2020-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first presentation of results from KEYNOTE-177, a Phase 3 trial evaluating KEYTRUDA, Mercks anti-PD-1 therapy, for the first-line treatment of patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) unresectable or metastatic colorectal cancer. In this pivotal study, KEYTRUDA monotherapy significantly reduced the risk of disease progression or death by 40% (HR=0.60 [95% CI, 0.45-0.80; p=0.0002]) and showed a median progression-free survival (PFS) of 16.5 months compared with 8.2 months for patients treated with chemotherapy (investigators choice of mFOLFOX6 or FOLFIRI, with or without bevacizumab or cetuximab), a current standard of care in this patient population. As previously announced, the study will continue without changes to evaluate overall survival (OS), the other dual primary endpoint. Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Merck’s KEYTRUDA (pembrolizumab) Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer – Maryville Daily Times

What is Coronary Artery Disease (CAD)? And Other Questions – HealthCentral.com

Posted: Published on May 29th, 2020

On this page:BasicsCausesRisk FactorsSymptomsHeart Attack Symptoms in WomenDiagnosisBest TreatmentsLifestyle ChangesMedicationsSurgery There are many different types of heart disease, but coronary artery disease, or CAD for short, is the most common. You might also hear it referred to as coronary heart disease or ischemic heart disease, but no matter what you call it, more than 18 million American adults have it, according to the Centers for Disease Control (CDC). And its not just a concern for older folks Continue reading →

Posted in Heart Diseases | Comments Off on What is Coronary Artery Disease (CAD)? And Other Questions – HealthCentral.com

High blood pressure before and after exercise linked to health issues in later life – Medical News Today

Posted: Published on May 29th, 2020

New research suggests that high blood pressure during and after exercise is linked to an increased risk of cardiovascular issues later in life. The study, appearing in the Journal of the American Heart Association, may help clinicians develop new prognostic tools for cardiovascular issues. Continue reading →

Posted in Heart Diseases | Comments Off on High blood pressure before and after exercise linked to health issues in later life – Medical News Today

American Indians and Alaska Natives have disproportionately higher rates of CVD – Science Codex

Posted: Published on May 29th, 2020

DALLAS, May 28, 2020 -- Type 2 diabetes (T2D) affects American Indians and Alaska Natives at approximately three times the rate of white Americans and is closely linked to the disproportionately high rates of cardiovascular diseases such as heart attacks and strokes, according to the American Heart Association Scientific Statement "Cardiovascular Health in American Indians and Alaska Natives," published today in the Association's flagship journal Circulation. Continue reading →

Posted in Heart Diseases | Comments Off on American Indians and Alaska Natives have disproportionately higher rates of CVD – Science Codex

Page 805«..1020..804805806807..810820..»